David Arthur
Chief Executive Officer presso SALARIUS PHARMACEUTICALS, INC.
Patrimonio netto: 25 992 $ in data 31/03/2024
Profilo
David J.
Arthur is currently the President, Chief Executive Officer & Director at Salarius Pharmaceuticals LLC since 2015.
He is also currently the Chief Executive Officer & Director at Salarius Pharmaceuticals, Inc. since 2019.
Previously, he worked as the Managing Director at Dacon Pharma LLC from 2012 to 2015.
Mr. Arthur completed his undergraduate degree at North Carolina State University and holds an MBA from The Fuqua School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 11/04/2024 | 49 135 ( 1.14% ) | 25 992 $ | 31/03/2024 |
Posizioni attive di David Arthur
| Società | Posizione | Inizio |
|---|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Chief Executive Officer | 19/07/2019 |
Salarius Pharmaceuticals LLC
 Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Chief Executive Officer | 01/11/2015 |
Precedenti posizioni note di David Arthur
| Società | Posizione | Fine |
|---|---|---|
| Dacon Pharma LLC | Corporate Officer/Principal | 01/10/2015 |
Formazione di David Arthur
| North Carolina State University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Salarius Pharmaceuticals LLC
Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Health Technology |
| Salarius Pharmaceuticals, Inc. | |
| Dacon Pharma LLC |
- Borsa valori
- Insiders
- David Arthur
